Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
2017 · Nature Medicine · 333 citations
https://doi.org/10.1038/nm.4378
S
Shangqian Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
839
Citations
14
h-index
18
i10-index
Shangqian Wang is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Urological Disorders and Treatments & Prostate Cancer Treatment and Research & Gastrointestinal Tumor Research and Treatment. The author has an h-index of 14, co-authored 43 publications.
ORCID: 0000-0002-5776-1973Papers by this author
worksThe influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma
2016 · Scientific Reports · 31 citations
https://doi.org/10.1038/srep20089
Retroperitoneal laparoscopic technique in treatment of complex renal stones: 75 cases
2014 · BMC Urology · 15 citations
https://doi.org/10.1186/1471-2490-14-16
Incidence And Risk Factors Of Inguinal Hernia Occurred After Radical Prostatectomy-comparisons of different approaches
2020 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-39693/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat